Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2016

08.08.2016 | Maternal-Fetal Medicine

Induction of labor: does indication matter?

verfasst von: Rinat Gabbay-Benziv, Eran Hadar, Eran Ashwal, Rony Chen, Arnon Wiznitzer, Liran Hiersch

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Labor induction is performed in 20 % of pregnancies. However, the impact of the indications for induction on its failure rate has hardly been investigated. We aimed to evaluate the association of indications for labor induction with failure rate.

Methods

Background and delivery-related data were retrospectively collected for all women with a viable term singleton pregnancy, who underwent labor induction with a PGE2 vaginal insert in 2013–2014. Reasons for induction were categorized as maternal indications, hypertensive disorders, premature rupture of membranes, and fetal indications. Induction failure was defined as Bishop score ≤7 at 24 h after PGE2 administration, cesarean delivery due to latent phase dystocia or removal of the insert due to non-reassuring fetal heart rate followed by emergency cesarean delivery. Outcome measures were rate of induction failure (primary) and rate of cesarean delivery (secondary).

Results

The cohort included 1066 women. Those who failed induction (n = 213, 20 %) were more likely to be nulliparous (69.5 vs. 45.7 %, p < 0.0001), older (31 vs. 30 years, p = 0.047), and at an earlier gestational age (39.4 vs. 40.0 weeks, p < 0.0001). Among nulliparous women, maternal indications were significantly associated with induction failure (aOR 2.52, 95 % CI 1.28–4.95, p = 0.007) and cesarean delivery (aOR 2.36, 95 % CI 0.40–2.29, p = 0.019). Among multiparous women, hypertensive disorders (aOR 7.26, 95 % CI 1.89–27.87, p = 0.004) and maternal indications (aOR 4.22, 95 %CI 1.14–15.58, p = 0.031) were significantly associated with induction failure but not cesarean delivery.

Conclusions

The indication for induction of labor may impact its failure rate.
Literatur
1.
Zurück zum Zitat Chauhan SP, Ananth CV (2012) Induction of in the United States: a critical appraisal of appropriateness and reducibility. Semin Perinatol 36:336–343CrossRefPubMed Chauhan SP, Ananth CV (2012) Induction of in the United States: a critical appraisal of appropriateness and reducibility. Semin Perinatol 36:336–343CrossRefPubMed
2.
Zurück zum Zitat American College of Obstetricians and Gynecologists (2009) Induction of labor. ACOG practice bulletin no. 107. Obstet Gynecol 114:386–397CrossRef American College of Obstetricians and Gynecologists (2009) Induction of labor. ACOG practice bulletin no. 107. Obstet Gynecol 114:386–397CrossRef
3.
Zurück zum Zitat Agency for Healthcare Research and Quality (2008) Maternal and neonatal outcomes of elective induction of labor. AHRQ, Rockville (MD) (AHRQ Evidence Report/Technology Assessment No.176) Agency for Healthcare Research and Quality (2008) Maternal and neonatal outcomes of elective induction of labor. AHRQ, Rockville (MD) (AHRQ Evidence Report/Technology Assessment No.176)
4.
Zurück zum Zitat Witter FR, Rocco LE, Johnson TR (1992) A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol 166:830–834CrossRefPubMed Witter FR, Rocco LE, Johnson TR (1992) A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term. Am J Obstet Gynecol 166:830–834CrossRefPubMed
5.
Zurück zum Zitat Gelber S, Sciscione A (2006) Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol 49:642–657CrossRefPubMed Gelber S, Sciscione A (2006) Mechanical methods of cervical ripening and labor induction. Clin Obstet Gynecol 49:642–657CrossRefPubMed
6.
Zurück zum Zitat Hofmeyr GJ, Gülmezoglu AM (2003) Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database Syst Rev 1:CD000941 Hofmeyr GJ, Gülmezoglu AM (2003) Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database Syst Rev 1:CD000941
7.
Zurück zum Zitat Vahratian A, Zhang J, Troendle JF, Sciscione AC, Hoffman MK (2005) Labor progression and risk of cesarean delivery in electively induced nulliparas. Obstet Gynecol 105:698–704CrossRefPubMed Vahratian A, Zhang J, Troendle JF, Sciscione AC, Hoffman MK (2005) Labor progression and risk of cesarean delivery in electively induced nulliparas. Obstet Gynecol 105:698–704CrossRefPubMed
8.
Zurück zum Zitat Rouse DJ, Owen J, Hauth JC (2000) Criteria for failed labor induction: prospective evaluation of a standardized protocol. Obstet Gynecol 96:671–677PubMed Rouse DJ, Owen J, Hauth JC (2000) Criteria for failed labor induction: prospective evaluation of a standardized protocol. Obstet Gynecol 96:671–677PubMed
9.
Zurück zum Zitat Isono W, Nagamatsu T, Uemura Y, Fujii T, Hyodo H, Yamashita T, Kamei Y, Kozuma S, Taketani Y (2011) Prediction model for the incidence of emergent cesarean section during induction of labor specialized in nulliparous low-risk women. J Obstet Gynaecol Res 2011(37):1784–1791CrossRef Isono W, Nagamatsu T, Uemura Y, Fujii T, Hyodo H, Yamashita T, Kamei Y, Kozuma S, Taketani Y (2011) Prediction model for the incidence of emergent cesarean section during induction of labor specialized in nulliparous low-risk women. J Obstet Gynaecol Res 2011(37):1784–1791CrossRef
10.
Zurück zum Zitat Ennen CS, Bofill JA, Magann EF, Bass JD, Chauhan SP, Morrison JC (2009) Risk factors for cesarean delivery in preterm, term and post-term patients undergoing induction of labor with an unfavorable cervix. Gynecol Obstet Invest 67:113–117CrossRefPubMed Ennen CS, Bofill JA, Magann EF, Bass JD, Chauhan SP, Morrison JC (2009) Risk factors for cesarean delivery in preterm, term and post-term patients undergoing induction of labor with an unfavorable cervix. Gynecol Obstet Invest 67:113–117CrossRefPubMed
11.
Zurück zum Zitat Cnattingius R, Hoglund B, Kieler H (2005) Emergency cesarean delivery in induction of labor: an evaluation of risk factors. Acta Obstet Gynecol Scand 84:456–462CrossRefPubMed Cnattingius R, Hoglund B, Kieler H (2005) Emergency cesarean delivery in induction of labor: an evaluation of risk factors. Acta Obstet Gynecol Scand 84:456–462CrossRefPubMed
12.
Zurück zum Zitat Roos N, Sahlin L, Ekman-Ordeberg G, Kieler H, Stephansson O (2010) Maternal risk factors for postterm pregnancy and cesarean delivery following labor induction. Acta Obstet Gynecol Scand 89:1003–1010CrossRefPubMed Roos N, Sahlin L, Ekman-Ordeberg G, Kieler H, Stephansson O (2010) Maternal risk factors for postterm pregnancy and cesarean delivery following labor induction. Acta Obstet Gynecol Scand 89:1003–1010CrossRefPubMed
13.
14.
Zurück zum Zitat Luthy DA, Malmgren JA, Zingheim RW (2004) Cesarean delivery after elective induction in nulliparous women: the physician effect. Am J Obstet Gynecol 191:1511–1515CrossRefPubMed Luthy DA, Malmgren JA, Zingheim RW (2004) Cesarean delivery after elective induction in nulliparous women: the physician effect. Am J Obstet Gynecol 191:1511–1515CrossRefPubMed
15.
Zurück zum Zitat Cammu H, Martens G, Ruyssinck G, Amy JJ (2002) Outcome after elective labor induction in nulliparous women: a matched cohort study. Am J Obstet Gynecol 186:240–244CrossRefPubMed Cammu H, Martens G, Ruyssinck G, Amy JJ (2002) Outcome after elective labor induction in nulliparous women: a matched cohort study. Am J Obstet Gynecol 186:240–244CrossRefPubMed
16.
Zurück zum Zitat Bailit JL, Gregory KD, Reddy UM, Gonzalez-Quintero VH, Hibbard JU, Ramirez MM, Branch DW, Burkman R, Haberman S, Hatjis CG, Hoffman MK, Kominiarek M, Landy HJ, Learman LA, Troendle J, Van Veldhuisen P, Wilkins I, Sun L, Zhang J (2010) Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 202:245.e1–245.e12CrossRef Bailit JL, Gregory KD, Reddy UM, Gonzalez-Quintero VH, Hibbard JU, Ramirez MM, Branch DW, Burkman R, Haberman S, Hatjis CG, Hoffman MK, Kominiarek M, Landy HJ, Learman LA, Troendle J, Van Veldhuisen P, Wilkins I, Sun L, Zhang J (2010) Maternal and neonatal outcomes by labor onset type and gestational age. Am J Obstet Gynecol 202:245.e1–245.e12CrossRef
17.
Zurück zum Zitat Pevzner L, Rayburn WF, Rumney P, Wing DA (2009) Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol 114:261–267CrossRefPubMed Pevzner L, Rayburn WF, Rumney P, Wing DA (2009) Factors predicting successful labor induction with dinoprostone and misoprostol vaginal inserts. Obstet Gynecol 114:261–267CrossRefPubMed
18.
19.
Zurück zum Zitat Tolcher MC, Holbert MR, Weaver AL, McGree ME, Olson JE, El-Nashar SA, Famuyide AO, Brost BC (2015) Predicting cesarean delivery after induction of labor among nulliparous women at term. Obstet Gynecol 126:1059–1068CrossRefPubMedPubMedCentral Tolcher MC, Holbert MR, Weaver AL, McGree ME, Olson JE, El-Nashar SA, Famuyide AO, Brost BC (2015) Predicting cesarean delivery after induction of labor among nulliparous women at term. Obstet Gynecol 126:1059–1068CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Parkes I, Kabiri D, Hants Y, Ezra Y (2016) The indication for induction of labor impacts the risk of cesarean delivery. J Matern Fetal Neonatal Med 29:224–228CrossRefPubMed Parkes I, Kabiri D, Hants Y, Ezra Y (2016) The indication for induction of labor impacts the risk of cesarean delivery. J Matern Fetal Neonatal Med 29:224–228CrossRefPubMed
21.
Zurück zum Zitat Gerli S, Favilli A, Giordano C, Bini V, Di Renzo GC (2013) Single indications of induction of labor with prostaglandins and risk of cesarean delivery: a retrospective cohort study. J Obstet Gynaecol Res 39:926–931CrossRefPubMed Gerli S, Favilli A, Giordano C, Bini V, Di Renzo GC (2013) Single indications of induction of labor with prostaglandins and risk of cesarean delivery: a retrospective cohort study. J Obstet Gynaecol Res 39:926–931CrossRefPubMed
22.
Zurück zum Zitat Simpson JL, Richards DS, Otano L (2012) Induction of labor. In: Gabbe SG, Niebyl JR, Simpson JL et al (eds) Obstetrics: normal and problem pregnancies, 6th edn. Saunders Elsevier, Philadelphia Simpson JL, Richards DS, Otano L (2012) Induction of labor. In: Gabbe SG, Niebyl JR, Simpson JL et al (eds) Obstetrics: normal and problem pregnancies, 6th edn. Saunders Elsevier, Philadelphia
23.
Zurück zum Zitat Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7:11–314 Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES (2005) Birth weight standards in the live-born population in Israel. Isr Med Assoc J 7:11–314
24.
Zurück zum Zitat Vrouenraets FP, Roumen FJ, Dehing CJ, van den Akker ES, Aarts MJ, Scheve EJ (2005) Bishop score and risk of cesarean delivery after induction of labor in nulliparous women. Obstet Gynecol 105:690–697CrossRefPubMed Vrouenraets FP, Roumen FJ, Dehing CJ, van den Akker ES, Aarts MJ, Scheve EJ (2005) Bishop score and risk of cesarean delivery after induction of labor in nulliparous women. Obstet Gynecol 105:690–697CrossRefPubMed
25.
Zurück zum Zitat Johnson DP, Davis NR, Brown AJ (2003) Risk of cesarean delivery after induction at term in nulliparous women with an unfavorable cervix. Am J Obstet Gynecol 188:1565–1570CrossRefPubMed Johnson DP, Davis NR, Brown AJ (2003) Risk of cesarean delivery after induction at term in nulliparous women with an unfavorable cervix. Am J Obstet Gynecol 188:1565–1570CrossRefPubMed
26.
Zurück zum Zitat Ehrenthal DB, Jianh X, Strobino DM (2010) Labor induction and the risk of a caesarean delivery among nulliparous women at term. Obstet Gynecol 116:35–42CrossRefPubMed Ehrenthal DB, Jianh X, Strobino DM (2010) Labor induction and the risk of a caesarean delivery among nulliparous women at term. Obstet Gynecol 116:35–42CrossRefPubMed
27.
Zurück zum Zitat Crowley P (2000). Interventions for preventing or improving outcome delivery at or beyond term. Cochrane Database Syst Rev 1(2):CD000170 Crowley P (2000). Interventions for preventing or improving outcome delivery at or beyond term. Cochrane Database Syst Rev 1(2):CD000170
28.
Zurück zum Zitat Melamed N, Yogev Y, Hadar E, Hod M, Ben-Haroush A (2008) Preinduction cervical ripening with prostaglandin E2 at preterm. Acta Obstet Gynecol Scand 87:63–67CrossRefPubMed Melamed N, Yogev Y, Hadar E, Hod M, Ben-Haroush A (2008) Preinduction cervical ripening with prostaglandin E2 at preterm. Acta Obstet Gynecol Scand 87:63–67CrossRefPubMed
29.
Zurück zum Zitat Heffner LJ, Elkin E, Fretts RC (2003) Impact of labor induction, gestational age, and maternal age on cesarean delivery rates. Obstet Gynecol 102:287–293PubMed Heffner LJ, Elkin E, Fretts RC (2003) Impact of labor induction, gestational age, and maternal age on cesarean delivery rates. Obstet Gynecol 102:287–293PubMed
30.
Zurück zum Zitat Seyb ST, Berka RJ, Socol ML, Dooley SL (1999) Risk of caesarean delivery with elective induction of labor at term in nulliparas. Obstet Gynecol 94:600–607PubMed Seyb ST, Berka RJ, Socol ML, Dooley SL (1999) Risk of caesarean delivery with elective induction of labor at term in nulliparas. Obstet Gynecol 94:600–607PubMed
Metadaten
Titel
Induction of labor: does indication matter?
verfasst von
Rinat Gabbay-Benziv
Eran Hadar
Eran Ashwal
Rony Chen
Arnon Wiznitzer
Liran Hiersch
Publikationsdatum
08.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2016
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-016-4171-1

Weitere Artikel der Ausgabe 6/2016

Archives of Gynecology and Obstetrics 6/2016 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.